Preservation of Fertility Potential for Gender and Sex Diverse Individuals

Transgender Health

Volumn 1, Issue 1, 2016, Pages 41-44

  Johnson, Emilie K ^a,b   Finlayson, Courtney ^a,b  

^a CHILDREN'S MEMORIAL HOSPITAL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

disorders of sex development; fertility preservation; gender dysphoria; transgender

Indexed keywords

TESTOSTERONE;

CRYOPRESERVATION; DISORDER OF SEX DEVELOPMENT; FERTILITY PRESERVATION; GENETIC COUNSELING; GONADECTOMY; HORMONAL THERAPY; HUMAN; MASTURBATION; OVARIAN TISSUE CRYOPRESERVATION; POPULATION RESEARCH; PRACTICE GUIDELINE; PREPUBERTY; PRIORITY JOURNAL; PROXY; PUBERTY; REVIEW; RISK FACTOR; TESTICULAR SPERM EXTRACTION; TRANSGENDER;

EID: 85013160499     PISSN: None     EISSN: 2380193X     Source Type: Journal    
DOI: 10.1089/trgh.2015.0010     Document Type: Review

References (21)

1. Lee PA, Houk CP, Ahmed SF, Hughes IA; International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. Pediatrics. 2006;118:e488-e500.
2. Lawrence AA, Shaffer JD, Snow WR, et al. Health care needs of transgendered patients. JAMA. 1996;276:874.
3. Wierckx K, Van Caenegem E, Pennings G, et al. Reproductive wish in transsexual men. Hum Reprod. 2012;27:483-487.
4. De Sutter P, Kira K, Verschoor A, Hotimsky A. The desire to have children and the preservation of fertility in transsexual women: a survey. Int J Transgend. 2003;6:3.
5. Hembree WC, Cohen-Kettenis P, Delemarre-van de Waal HA, et al. Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2009;94:3132-3154.
6. Hagen CP, Sorensen K, Anderson RA, Juul A. Serum levels of antimullerian hormone in early maturing girls before, during, and after suppression with GnRH agonist. Fertil Steril. 2012;98:1326-1330.
7. Hembree WC. Guidelines for pubertal suspension and gender reassignment for transgender adolescents. Child Adolesc Psychiatr Clin N Am. 2011;20:725-732.
8. Schulze C. Response of the human testis to long-term estrogen treatment: morphology of Sertoli cells, Leydig cells and spermatogonial stem cells. Cell Tissue Res. 1988;251:31-43.
9. Lubbert H, Leo-Rossberg I, Hammerstein J. Effects of ethinyl estradiol on semen quality and various hormonal parameters in a eugonadal male. Fertil Steril. 1992;58:603-608.
10. Pache TD, Chadha S, Gooren LJ, et al. Ovarian morphology in long-term androgen-treated female to male transsexuals. A human model for the study of polycystic ovarian syndrome? Histopathology. 1991;19:445-452.
11. Ikeda K, Baba T, Noguchi H, et al. Excessive androgen exposure in femaleto-male transsexual persons of reproductive age induces hyperplasia of the ovarian cortex and stroma but not polycystic ovary morphology. Hum Reprod. 2013;28:453-461.
12. Light AD, Obedin-Maliver J, Sevelius JM, Kerns JL. Transgender men who experienced pregnancy after female-to-male gender transitioning. Obstet Gynecol. 2014;124:1120-1127.
13. Ellis SA, Wojnar DM, Pettinato M. Conception, pregnancy, and birth experiences of male and gender variant gestational parents: it's how we could have a family. J Midwifery Womens Health. 2015;60:62-69.
14. Loren AW, Mangu PB, Beck LN, et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31:2500-2510.
15. Estes SJ. Fertility Preservation in Children and Adolescents. Endocrinol Metab Clin North Am. 2015;44:799-820.
16. Gies I, De Schepper J, Tournaye H. Progress and prospects for fertility preservation in prepubertal boys with cancer. Curr Opin Endocrinol Diabetes Obes. 2015;22:203-208.
17. Trudgen K, Ayensu-Coker L. Fertility preservation and reproductive health in the pediatric, adolescent, and young adult female cancer patient. Curr Opin Obstet Gynecol. 2014;26:372-380.
18. Aksglaede L, Juul A. Testicular function and fertility in men with Klinefelter syndrome: a review. Eur J Endocrinol. 2013;168:R67-R76.
19. Tordjman KM, Yaron M, Berkovitz A, et al. Fertility after high-dose testosterone and intracytoplasmic sperm injection in a patient with androgen insensitivity syndrome with a previously unreported androgen receptor mutation. Andrologia. 2014;46:703-706.
20. Matsubara K, Iwamoto H, Yoshida A, Ogata T. Semen analysis and successful paternity by intracytoplasmic sperm injection in a man with steroid 5alpha-reductase-2 deficiency. Fertil Steril. 2010;94:2770. e7-e10.
21. Kang HJ, Imperato-McGinley J, Zhu YS, et al. The first successful paternity through in vitro fertilization-intracytoplasmic sperm injection with a man homozygous for the 5alpha-reductase-2 gene mutation. Fertil Steril. 2011;95:2125 e5-e8.